Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value
March 26, 2025 13:58 ET | Source: Atea Pharmaceuticals, Inc. BOSTON, March…
Atea Pharmaceuticals Issues Statement Regarding Director Nominations
No Shareholder Action is Required at this Time March 21, 2025 17:54…
Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
March 21, 2025 16:30 ET | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE,…
SI Group Awarded Bronze Medal by EcoVadis for Corporate Social Responsibility
Company Ranked in the Top 35% of All Rated Companies Underscoring the…
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens Cancer
March 15, 2025 11:25 ET | Source: ZENTALIS PHARMACEUTICALS Azenosertib median duration…
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful…
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
– Company generated quarterly sequential growth in YCANTH® dispensed applicator units of…
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025 16:30 ET | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO,…
Amaran Biotech Signs MOU with Nippon Fine Chemical
TAIPEI, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Amaran Biotechnology Inc., a…
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
March 05, 2025 17:52 ET | Source: Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass.,…